Back to discover
Drug

Dehydroepiandrosterone Sulfate

In clinical development
Emerging researchLate-stage development
Also known as (3-beta)-3-(Sulfooxy)androst-5-en-17-one, 3-O-Sulfodehydroepiandrosterone, Androst-5-en-17-on-3beta-yl sulfuric acid, DHEA-S+15 more

(3-beta)-3-(Sulfooxy)androst-5-en-17-one, 3-O-Sulfodehydroepiandrosterone, Androst-5-en-17-on-3beta-yl sulfuric acid, DHEA-S, 17-Ketoandrost-5-en-3beta-yl sulfate, 3beta-Hydroxyandrost-5-en-17-one 3-sulfate, DHAS - Dehydroepiandrosterone sulfate, DHAS - Dehydroepiandrosterone sulphate, DHEA sulfate, DHEA sulphate, DHEAS - Dehydroepiandrosterone sulfate, DHEAS - Dehydroepiandrosterone sulphate, Dehydroepiandrosterone 3-sulfate, Dehydroepiandrosterone monosulfate, Dehydroepiandrosterone sulphate, Dehydroisoandrosterone sulfate, Dehydroisoandrosterone-3-sulfate, Prasterone sulfate, Prasterone sulphate.

RxNorm22415ChEMBLCHEMBL259898UNII57B09Q7FJR
2
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Dehydroepiandrosterone Sulfate
Aliases & brands
(3-beta)-3-(Sulfooxy)androst-5-en-17-one3-O-SulfodehydroepiandrosteroneAndrost-5-en-17-on-3beta-yl sulfuric acidDHEA-S17-Ketoandrost-5-en-3beta-yl sulfate3beta-Hydroxyandrost-5-en-17-one 3-sulfateDHAS - Dehydroepiandrosterone sulfateDHAS - Dehydroepiandrosterone sulphateDHEA sulfateDHEA sulphateDHEAS - Dehydroepiandrosterone sulfateDHEAS - Dehydroepiandrosterone sulphateDehydroepiandrosterone 3-sulfateDehydroepiandrosterone monosulfateDehydroepiandrosterone sulphateDehydroisoandrosterone sulfateDehydroisoandrosterone-3-sulfatePrasterone sulfatePrasterone sulphate
RxNorm CUI
22415
ChEMBL ID
CHEMBL259898
UNII
57B09Q7FJR

Clinical trials

1 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
1
registered trials across all phases
1
Late-stage (III+)
1
Discontinued
PHASE DISTRIBUTIONn = 1
Phase 31

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Etude de l'Activite (Efficacite et Tolerance) de l'Association de la Chloroquine Avec la Dehydroepiandrosterone-Sulfate (Dheas) Dans le Traitement de l'Acces Palustre Simple A Plasmodium Falciparum

SuspendedPH IIIUniversité Victor Segalen Bordeaux 2n=2002002

Research activity

2 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
20232024
Major research themes8
Anorexia Nervosa1Blood Glucose1Body Mass Index1Diet, Ketogenic1Dietary Carbohydrates1Obesity1Overweight1Polycystic Ovary Syndrome1
Journals, researchers & institutions
Top journals
  • European journal of endocrinology1
  • Nutrition journal1
Leading researchers
  • Fazeli PK1
  • Jahan-Mihan A1
  • Moludi J1
  • Saber A1
  • Salimi Y1
  • Sharifi M1
  • Thavaraputta S1
  • Ungprasert P1
Leading institutions
free-text, unnormalised
  • Brooks College of Health1
  • Chulalongkorn University and Excellence Center in Diabetes1
  • Cleveland Clinic1
  • Research Center for Environmental Determinants of Health1
  • School of Nutritional Sciences and Food Technology1
  • Social Development & Health Promotion Research Center1

Related drugs

7 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Insulin

Studied across 3 of the same disease areas as Dehydroepiandrosterone Sulfate in the shared literature.

3 shared diseases1 shared paper
Luteinizing Hormone

Studied across 3 of the same disease areas as Dehydroepiandrosterone Sulfate in the shared literature.

3 shared diseases1 shared paper
Testosterone

Studied across 3 of the same disease areas as Dehydroepiandrosterone Sulfate in the shared literature.

3 shared diseases1 shared paper
Triglycerides

Studied across 3 of the same disease areas as Dehydroepiandrosterone Sulfate in the shared literature.

3 shared diseases1 shared paper
Hydrocortisone

Studied across 2 of the same disease areas as Dehydroepiandrosterone Sulfate in the shared literature.

2 shared diseases1 shared paper
Progesterone

Studied across 2 of the same disease areas as Dehydroepiandrosterone Sulfate in the shared literature.

2 shared diseases1 shared paper
Aldosterone

Studied across the same disease area as Dehydroepiandrosterone Sulfate in the shared literature.

1 shared disease1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials